newsfilter
← Latest News
GlobeNewswire·

Oragenics Selects Southern Star Research as Clinical Research Organization for ONP-002 Phase IIa Trial

SARASOTA, Fla., July 31, 2025 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE:OGEN), a clinical-stage biotechnology company pioneering intranasal drug delivery for neurological conditions, today announced the selection of